Cargando…

Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration

BACKGROUND: Gut microbiota may be altered in patients with cirrhosis, and may further change after administration of lactulose. We studied the composition of gut microbiota in patients with cirrhosis and assessed the effect on it of lactulose administration. METHODS: Stool specimens were collected f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarangi, Aditya Narayan, Goel, Amit, Singh, Ankur, Sasi, Avani, Aggarwal, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704526/
https://www.ncbi.nlm.nih.gov/pubmed/29179682
http://dx.doi.org/10.1186/s12876-017-0683-9
_version_ 1783281914675724288
author Sarangi, Aditya Narayan
Goel, Amit
Singh, Ankur
Sasi, Avani
Aggarwal, Rakesh
author_facet Sarangi, Aditya Narayan
Goel, Amit
Singh, Ankur
Sasi, Avani
Aggarwal, Rakesh
author_sort Sarangi, Aditya Narayan
collection PubMed
description BACKGROUND: Gut microbiota may be altered in patients with cirrhosis, and may further change after administration of lactulose. We studied the composition of gut microbiota in patients with cirrhosis and assessed the effect on it of lactulose administration. METHODS: Stool specimens were collected from 35 patients with cirrhosis (male 26; median [range] age: 42 [29–65] years) and 18 healthy controls (male 14; 44.5 [24–67] years); 21 patients provided another specimen after lactulose administration for 55 [42–77] days. For each, a DNA library of V3 region of bacterial 16S ribosomal RNA was subjected to paired-end Illumina sequencing. Inter-specimen relationship was studied using principal co-ordinate analysis. Abundances of various bacterial taxa, and indices of alpha and beta diversity were compared, between patients and controls, and between specimens collected before and after lactulose. RESULTS: Gut microbiota from cirrhosis patients and controls showed differential clustering, and microbiota from patients with cirrhosis had less marked alpha diversity. Abundances of dominant phyla (Bacteroidetes, Firmicutes and Proteobacteria) were similar. However, patients with cirrhosis had lower abundances of five phyla, namely Tenericutes, Cyanobacteria, Spirochaetes, Elusimicrobia and Lentisphaerae, and differences in abundances of several families and genera than in controls. Lactulose administration did not lead to any change in alpha and beta diversities, species richness and abundances of various bacterial taxa in gut microbiota. CONCLUSIONS: Gut microbiota in cirrhosis differ from healthy persons and do not change following lactulose administration. The latter suggests that the effect of lactulose on hepatic encephalopathy may not be related to alteration in gut microbiota. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-017-0683-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5704526
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57045262017-12-05 Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration Sarangi, Aditya Narayan Goel, Amit Singh, Ankur Sasi, Avani Aggarwal, Rakesh BMC Gastroenterol Research Article BACKGROUND: Gut microbiota may be altered in patients with cirrhosis, and may further change after administration of lactulose. We studied the composition of gut microbiota in patients with cirrhosis and assessed the effect on it of lactulose administration. METHODS: Stool specimens were collected from 35 patients with cirrhosis (male 26; median [range] age: 42 [29–65] years) and 18 healthy controls (male 14; 44.5 [24–67] years); 21 patients provided another specimen after lactulose administration for 55 [42–77] days. For each, a DNA library of V3 region of bacterial 16S ribosomal RNA was subjected to paired-end Illumina sequencing. Inter-specimen relationship was studied using principal co-ordinate analysis. Abundances of various bacterial taxa, and indices of alpha and beta diversity were compared, between patients and controls, and between specimens collected before and after lactulose. RESULTS: Gut microbiota from cirrhosis patients and controls showed differential clustering, and microbiota from patients with cirrhosis had less marked alpha diversity. Abundances of dominant phyla (Bacteroidetes, Firmicutes and Proteobacteria) were similar. However, patients with cirrhosis had lower abundances of five phyla, namely Tenericutes, Cyanobacteria, Spirochaetes, Elusimicrobia and Lentisphaerae, and differences in abundances of several families and genera than in controls. Lactulose administration did not lead to any change in alpha and beta diversities, species richness and abundances of various bacterial taxa in gut microbiota. CONCLUSIONS: Gut microbiota in cirrhosis differ from healthy persons and do not change following lactulose administration. The latter suggests that the effect of lactulose on hepatic encephalopathy may not be related to alteration in gut microbiota. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-017-0683-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-28 /pmc/articles/PMC5704526/ /pubmed/29179682 http://dx.doi.org/10.1186/s12876-017-0683-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sarangi, Aditya Narayan
Goel, Amit
Singh, Ankur
Sasi, Avani
Aggarwal, Rakesh
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title_full Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title_fullStr Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title_full_unstemmed Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title_short Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
title_sort faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704526/
https://www.ncbi.nlm.nih.gov/pubmed/29179682
http://dx.doi.org/10.1186/s12876-017-0683-9
work_keys_str_mv AT sarangiadityanarayan faecalbacterialmicrobiotainpatientswithcirrhosisandtheeffectoflactuloseadministration
AT goelamit faecalbacterialmicrobiotainpatientswithcirrhosisandtheeffectoflactuloseadministration
AT singhankur faecalbacterialmicrobiotainpatientswithcirrhosisandtheeffectoflactuloseadministration
AT sasiavani faecalbacterialmicrobiotainpatientswithcirrhosisandtheeffectoflactuloseadministration
AT aggarwalrakesh faecalbacterialmicrobiotainpatientswithcirrhosisandtheeffectoflactuloseadministration